Andy Shih is senior vice president of public health and inclusion at Autism Speaks in New York City.
Andy Shih
Senior vice president of public health and inclusion
Autism Speaks
From this contributor
Remembering Zemi Yenus: An ambassador for autism in Africa
Zemi Yenus was the mother of a child with autism, founder of Ethiopia’s first school for autistic children and a tireless advocate for autism awareness and research in Africa.
Remembering Zemi Yenus: An ambassador for autism in Africa
By
Rosa Hoekstra, Andy Shih, Bethlehem Tekola, Waganesh Zeleke
15 June 2021 | 13 min read
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
By
Ashley Juavinett
30 March 2026 | 8 min read
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
By
Dalmeet Singh Chawla
27 March 2026 | 5 min read
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
By
Claudia López Lloreda
26 March 2026 | 4 min read